http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8585430

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 892
issn 1365-2125
0306-5251
issueIdentifier 6
pageRange 885-892
publicationName British Journal of Clinical Pharmacology
startingPage 885
bibliographicCitation Wang Y, Zhou L, Dutreix C, Leroy E, Yin Q, Sethuraman V, Riviere G, Yin OQP, Schran H, Shen Z. Effects of imatinib (Glivec) on the pharmacokinetics of metoprolol, a CYP2D6 substrate, in Chinese patients with chronic myelogenous leukaemia. Brit J Clinical Pharma. 2008 Apr 03;65(6):885–92. doi: 10.1111/j.1365-2125.2008.03150.x.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f1f745e20af45fbf90470b6765543b2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9a8fa88ebb54bc78ad886e41bb8fec1b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d86c6d4b16e9f8ff4d830587ebbf50b5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6ee6c99228a60e37cf3f582ec99539d8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a474772d9e4edf30541b66c7fad0791c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_651c6ee17a5c3b0d42be252319d800bf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_09f3d28b3021e35658ac7002adc94dbb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5cf5e3b8ea3b85518d117de92846064b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6383198353970953bb6d952516e8fbb5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3bb627df2803f465d555433d610346a9
date 2008-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC2485214
https://pubmed.ncbi.nlm.nih.gov/18384443
https://doi.org/10.1111/j.1365-2125.2008.03150.x
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1743
https://portal.issn.org/resource/ISSN/0306-5251
https://portal.issn.org/resource/ISSN/1365-2125
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Effects of imatinib (Glivec) on the pharmacokinetics of metoprolol, a CYP2D6 substrate, in Chinese patients with chronic myelogenous leukaemia
discusses http://id.nlm.nih.gov/mesh/M0018260
http://id.nlm.nih.gov/mesh/M0002327
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0016884
http://id.nlm.nih.gov/mesh/M0391958
http://id.nlm.nih.gov/mesh/M0000495
http://id.nlm.nih.gov/mesh/M0013686
http://id.nlm.nih.gov/mesh/M0028855
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D008790Q000493
http://id.nlm.nih.gov/mesh/D010879Q000494
http://id.nlm.nih.gov/mesh/D015464Q000188
http://id.nlm.nih.gov/mesh/D000970Q000493
http://id.nlm.nih.gov/mesh/D011743Q000494
http://id.nlm.nih.gov/mesh/D000319Q000493
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000068877
http://id.nlm.nih.gov/mesh/D019389Q000235
http://id.nlm.nih.gov/mesh/D001549
http://id.nlm.nih.gov/mesh/D008790Q000627
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D011743Q000627
http://id.nlm.nih.gov/mesh/D000319Q000627
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D000970Q000627
http://id.nlm.nih.gov/mesh/D011110
http://id.nlm.nih.gov/mesh/D015464Q000378
http://id.nlm.nih.gov/mesh/D044466Q000235
http://id.nlm.nih.gov/mesh/D013223
http://id.nlm.nih.gov/mesh/D015464Q000235
http://id.nlm.nih.gov/mesh/D004347
http://id.nlm.nih.gov/mesh/D010879Q000627
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f258d559df86a3ecbbb4d5a4da82aa1f
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123596
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4171

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1565
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128220647

Total number of triples: 74.